Experts Highlight Anticipated Research to Be Revealed at ESMO 2019

Experts Highlight Anticipated Research to Be Revealed at ESMO 2019

Highlights from ESMO 2019Подробнее

Highlights from ESMO 2019

Expert highlights: Genitourinary cancers at ESMO 2019 | Axel MerseburgerПодробнее

Expert highlights: Genitourinary cancers at ESMO 2019 | Axel Merseburger

Expert highlights: Lung and thoracic cancers at ESMO 2019 | Ross CamidgeПодробнее

Expert highlights: Lung and thoracic cancers at ESMO 2019 | Ross Camidge

John Strickler: ESMO 2019 HighlightsПодробнее

John Strickler: ESMO 2019 Highlights

Breast cancer highlights from ESMO 2019Подробнее

Breast cancer highlights from ESMO 2019

ESMO 2019 Daily Reporter - Editor's Picks: Ovarian cancerПодробнее

ESMO 2019 Daily Reporter - Editor's Picks: Ovarian cancer

All set for ESMO 2019!Подробнее

All set for ESMO 2019!

Expert highlights: RCC immunotherapy at ESMO 2019 | Axel MerseburgerПодробнее

Expert highlights: RCC immunotherapy at ESMO 2019 | Axel Merseburger

ESMO Congress 2019 Daily Reporter - Editor's Picks: Prostate cancerПодробнее

ESMO Congress 2019 Daily Reporter - Editor's Picks: Prostate cancer

ESMO 2019 Daily Reporter - Editor's Picks: Lung cancerПодробнее

ESMO 2019 Daily Reporter - Editor's Picks: Lung cancer

Jarrod Longcor: ESMO highlightsПодробнее

Jarrod Longcor: ESMO highlights

ESMO 2019 – the best bits!Подробнее

ESMO 2019 – the best bits!

ESMO 2019, Barcelona Day 1 HighlightsПодробнее

ESMO 2019, Barcelona Day 1 Highlights

Highlights from ESMO Sarcoma & GIST 2022Подробнее

Highlights from ESMO Sarcoma & GIST 2022

ESMO 2022 highlightsПодробнее

ESMO 2022 highlights

Experts reflect on their highlights from ESMO 2018Подробнее

Experts reflect on their highlights from ESMO 2018

Melanoma highlights from ESMO 2019Подробнее

Melanoma highlights from ESMO 2019

ESMO 2019, Barcelona Day 2 HighlightsПодробнее

ESMO 2019, Barcelona Day 2 Highlights

#ESMO22 Highlights on pembrolizumab with CRT in locally advanced HNSCC: The KEYNOTE-412 studyПодробнее

#ESMO22 Highlights on pembrolizumab with CRT in locally advanced HNSCC: The KEYNOTE-412 study

Актуальное